Investindustrial Acquires Proveris Scientific Corporation, a Leading Global Manufacturer of Analytical Testing Instrumentation for the Pharmaceutical Industry

NEW YORK--(BUSINESS WIRE)--An independently managed investment subsidiary of Investindustrial Growth III SCSp (“Investindustrial”) has acquired Proveris Scientific Corporation (“Proveris”), a leader in the design and manufacture of spray and aerosol testing instrumentation, software and laboratory solutions for the pharmaceutical industry with a specialization on orally inhaled and nasal drug products (“OINDP”).

Founded by Dino J. Farina, and headquartered in Hudson, Massachusetts, Proveris has been serving the world’s leading pharmaceutical companies since 1995 and is the global provider of choice for spray characterization testing instrumentation, lab services and OINDP expertise. Proveris’ technologies are deeply embedded in customer workflows and regulatory processes, supporting reproducibility, data continuity, and long-term customer relationships. In serving a diverse and global customer base of branded and generic pharmaceutical companies, contract development organizations, device makers and regulatory agencies, Proveris’ technologies and expertise are integral to organizations for OINDP approvals in more than 30 countries.

Through its investment in and in partnership with Proveris’ management, Investindustrial aims to drive further Proveris’ expansion and build a leading pharmaceutical testing equipment group positioned for continued global growth, both through organic and acquisitive expansion in its existing markets and in adjacent pharmaceutical testing equipment categories. With a global reputation for innovation and quality and a broad international sales base, Proveris is exceptionally well positioned to serve as the ideal foundation for this ambitious growth strategy.

Building on the proven success of its affiliates in providing advisory support to companies across the equipment, automation and healthcare industries, with investments such as Arterex, Ourvita, GeneraLife, Lifebrain, and Omnia Technologies, Investindustrial brings the deep sector experience, integration capabilities, operational expertise and global presence needed to support Proveris’ continued development while preserving its science-led culture and customer focus.

Founder Dino Farina, a pioneer in the OINDP testing equipment industry, will remain with Proveris and has reinvested as a minority shareholder alongside Investindustrial, reinforcing Investindustrial’s reputation as the partner of choice for ambitious founders, entrepreneurs and family business owners.

Andrea C. Bonomi, Chairman of the Investindustrial Industrial Advisory Board, said: "Proveris represents an exceptional platform to build a global leader in specialty pharmaceutical testing equipment. We greatly admire what Dino and the team have achieved and look forward to partnering on the next phase of growth. By leveraging our industrial expertise, international reach, and strong integration capabilities, we aim to accelerate growth and expand the company’s global footprint.”

Dino Farina, Founder & CEO of Proveris, said: “Investindustrial represents everything I could hope for in a partner focused on strategic growth, investment and value creation for Proveris’ customers and the Proveris team. I am very excited for the future working with the Investindustrial team.”

Investindustrial was advised by EuroConsult, Inc. as financial advisor and White & Case LLP as legal advisors.

The sellers were advised by City Capital Advisors as exclusive financial advisor and Mirick O’Connell DeMallie & Lougee LLP as legal advisor.

About Investindustrial

Investindustrial is a leading European group of independently managed investment, holding and advisory companies with €17 billion of raised fund capital. With ESG principles deeply embedded into the Firm’s core approach, Investindustrial has a 35-year history of providing midmarket companies with capital, industrial expertise, operational focus and global platforms to accelerate sustainable value creation and international expansion.

Certain companies of the Investindustrial group are authorised by, and subject to regulatory supervision of the FCA in the United Kingdom, the CSSF in Luxembourg and the FSRA in Abu Dhabi Global Markets. References to ‘Investindustrial’ are of generic nature, for ease of reading, and may refer, depending on the context, to a fund or any of its independently managed subsidiaries. Investindustrial’s investment companies act independently from each other and each Investindustrial fund. Additional information is available at www.investindustrial.com.

The terms “group”, “Investindustrial”, “we”, “us” (and similar) in this document have been used only for practical ease of reading and do not intend to imply any specific reference to a legal definition or any activity of control by any individual or company with respect to other companies. Investindustrial companies are each independently managed by their respective boards of directors. The term “Investindustrial” may refer where the context requires to companies other than the investment subsidiary of the fund.

This document (“Document”) has been prepared for information purposes only. Neither the whole nor any of the information in this Document may be used for any other purpose without the prior written consent of Investindustrial. Any reproduction or distribution of this Document, in whole or in part, or the disclosure of its contents, without the prior written consent of Investindustrial, is prohibited. No warranty or assurance is given on the accuracy of the information. All statements of opinion and/or beliefs contained in this Document, and all views expressed and all projections, forecasts and statements regarding future events, expectations or future performance or returns represent Investindustrial’s own assessment and interpretation of information available to it at the date of this Document.

Investors must determine for themselves what reliance (if any) they should place on such views, projections, statements or forecasts and no responsibility is accepted by Investindustrial in respect thereof. Investors should not treat this Document as comprising any element of advice relating to legal, taxation, accounting or investment matters and are advised to consult their own professional advisors concerning the potential acquisition, holding or disposal of an investment. Past performance is not a reliable indicator of future performance and any past performance information contained in this Document is not an indication of future performance.

It has not been audited or verified by an independent party and should not be seen as any indication of returns which might be received by investors. This Document does not constitute an offer or invitation to subscribe or purchase securities or other financial instruments and the information contained herein is subject to updating, amendment and verification. It should not be relied upon by any persons for any purpose.

For further information please contact

Julia Fisher, Edelman Smithfield
Julia.Fisher@edelmansmithfield.com